<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Complications associated with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) can include <z:hpo ids='HP_0002043'>esophageal stricture</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:hpo ids='HP_0002239'>gastrointestinal hemorrhage</z:hpo>, and extraesophageal symptoms </plain></SENT>
<SENT sid="1" pm="."><plain>The impact of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>-associated complications on health-care utilization deserves further evaluation </plain></SENT>
<SENT sid="2" pm="."><plain>We identified commercial enrollees 18-75 years old with claims for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (International Classification of Diseases, Ninth Revision, Clinical Modification Codes: 530.81 or 530.11) and subsequent usage of <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> from 01/01/05 to 06/30/09 </plain></SENT>
<SENT sid="3" pm="."><plain>The initial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> diagnosis date was designated as the index date, and patients were studied for 6 months preindex and postindex </plain></SENT>
<SENT sid="4" pm="."><plain>Eligible patients were subsequently stratified based on medical claims for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>-associated complications as follows: stage A (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> diagnosis, no other symptoms), stage B (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> + extraesophageal symptoms), stage C (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> + <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>), stage D (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> + <z:hpo ids='HP_0002043'>esophageal stricture</z:hpo>), and stage E (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> + <z:hpo ids='HP_0001891'>iron-deficiency anemia</z:hpo> or <z:hpo ids='HP_0011009'>acute</z:hpo> upper <z:hpo ids='HP_0002239'>gastrointestinal hemorrhage</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>Patient characteristics, health-care utilization, and costs were compared between stage A and each stage with complicated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (B-D) </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 174,597 patients who were eligible for analysis, 74% were classified as stage A, 20% stage B, 1% stage C, 2% stage D, and 3% stage E </plain></SENT>
<SENT sid="7" pm="."><plain>Relative to stage A, patients in stages C, D, and E were significantly more likely to visit a gastroenterologist (13% vs. 68%, 71%, and 38%, respectively) and had higher rates of <z:mp ids='MP_0004547'>esophageal ulcers</z:mp> (0.3% vs. 8%, 5%, and 3%, respectively) and Nissen fundoplication (0.05% vs. 0.6%, 0.3%, and 0.2%, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Six-month <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>-related costs ranged from $615/patient (stage A) to $1714/patient (stage D); <z:hpo ids='HP_0000001'>all</z:hpo>-cause costs ranged from $4195/patient (stage A) to $11,340/patient (stage E) </plain></SENT>
<SENT sid="9" pm="."><plain>Compared with stage A, <z:hpo ids='HP_0000001'>all</z:hpo> other cohorts had significantly higher <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>-related costs (P &lt; 0.0001 for <z:hpo ids='HP_0000001'>all</z:hpo> comparisons) </plain></SENT>
<SENT sid="10" pm="."><plain>While patients with more severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> represented a relatively small portion of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> cohort, they demonstrated significantly greater health-care costs and overall utilization than patients with uncomplicated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
</text></document>